AiXin Life International (AIXN) EBITDA Margin (2017 - 2025)
AiXin Life International's (AIXN) quarterly EBITDA Margin came in at 207.59% in Q4 2025, down 5190.0% year-over-year from 4.08% in Q4 2024, and down 80.54% quarter-over-quarter from 114.98% in Q3 2025.
Powered by 
Analysis
AiXin Life International (AIXN) EBITDA Margin (2017 - 2025) Analysis & Trends
AiXin Life International (AIXN) has reported EBITDA Margin for 9 consecutive years, with 207.59% the latest figure, recorded in Q4 2025.
- On a quarterly basis, EBITDA Margin fell 5190.0% year-over-year to 207.59% in Q4 2025; TTM through Dec 2025 was 169.23%, a 10155.0% decrease from a year earlier, with the FY2025 full-year figure at 169.23%, down 10155.0% from the prior year.
- EBITDA Margin was 207.59% for Q4 2025 at AiXin Life International, down from 114.98% in the prior quarter.
- Over five years, EBITDA Margin peaked at 54.94% in Q2 2021 and troughed at 207.59% in Q4 2025.
- A 5-year average of 88.42% and a median of 76.25% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin tumbled 23058 bps in 2022 and soared 16854 bps in 2023, its largest moves.
- Over 5 years, EBITDA Margin stood at 88.85% in 2021, then soared by 51 bps to 43.82% in 2022, then plunged by 219 bps to 139.73% in 2023, then decreased by 11 bps to 155.69% in 2024, then slumped by 33 bps to 207.59% in 2025.
- The last three EBITDA Margin figures came in at 207.59% (Q4 2025), 114.98% (Q3 2025), and 175.87% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn | 18.95% |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn | 17.67% |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn | 15.11% |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn | 14.27% |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - | - |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn | 2.30% |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn | 4.39% |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn | 9.67% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | AiXin Life International | 6.50 Mn | 6.48 Mn | 215,023.00 | -207.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -207.59% |
| Sep 30, 2025 | -114.98% |
| Jun 30, 2025 | -175.87% |
| Mar 31, 2025 | -171.12% |
| Dec 31, 2024 | -155.69% |
| Sep 30, 2024 | -64.35% |
| Jun 30, 2024 | -20.17% |
| Mar 31, 2024 | -72.95% |
| Dec 31, 2023 | -139.73% |
| Sep 30, 2023 | -68.91% |
| Jun 30, 2023 | -7.10% |
| Mar 31, 2023 | -73.14% |
| Dec 31, 2022 | -43.82% |
| Sep 30, 2022 | -79.36% |
| Jun 30, 2022 | -175.64% |
| Mar 31, 2022 | -184.43% |
| Dec 31, 2021 | -88.85% |
| Sep 30, 2021 | -11.50% |
| Jun 30, 2021 | 54.94% |
| Mar 31, 2021 | 31.82% |